New Zealand - English - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - prasugrel hydrochloride 10.98mg - film coated tablet - 10 mg - active: prasugrel hydrochloride 10.98mg excipient: croscarmellose sodium glycerol hypromellose iron oxide red iron oxide yellow lactose magnesium stearate mannitol microcrystalline cellulose purified talc titanium dioxide - effient, co-administered with aspirin, is indicated for the prevention of atherothrombotic events (myocardial infarction, stroke and cardiovascular death) in patients with acute coronary syndromes (moderate to high risk unstable angina (ua), non st-segment elevation myocardial infarction (nstemi) or st-segment elevation myocardial infarction (stemi)) who are to undergo percutaneous coronary intervention (pci).

New Zealand - English - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - prasugrel hydrochloride 5.49mg - film coated tablet - 5 mg - active: prasugrel hydrochloride 5.49mg excipient: croscarmellose sodium glycerol hypromellose iron oxide yellow lactose magnesium stearate mannitol microcrystalline cellulose purified talc titanium dioxide - effient, co-administered with aspirin, is indicated for the prevention of atherothrombotic events (myocardial infarction, stroke and cardiovascular death) in patients with acute coronary syndromes (moderate to high risk unstable angina (ua), non st-segment elevation myocardial infarction (nstemi) or st-segment elevation myocardial infarction (stemi)) who are to undergo percutaneous coronary intervention (pci).

Australia - English - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - factor viii inhibitor bypassing fraction, quantity: 1000 mg - injection, powder for - excipient ingredients: sodium citrate dihydrate; sodium chloride - feiba-nf is indicated for routine prophylaxis, control of spontaneous bleeding episodes and use in surgery in haemophilia a or b patients with inhibitors.

Australia - English - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - factor viii inhibitor bypassing fraction, quantity: 1000 u - injection, powder for - excipient ingredients: sodium citrate dihydrate; sodium chloride - feiba-nf is indicated for routine prophylaxis, control of spontaneous bleeding episodes and use in surgery in haemophilia a or b patients with inhibitors.

Australia - English - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - factor viii inhibitor bypassing fraction, quantity: 500 u - injection, powder for - excipient ingredients: sodium citrate dihydrate; sodium chloride - feiba-nf is indicated for routine prophylaxis, control of spontaneous bleeding episodes and use in surgery in haemophilia a or b patients with inhibitors.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

the hunter river company pty limited - levamisole hydrochloride; albendazole oxide - oral solution/suspension - levamisole hydrochloride anthelmintic active 82.5 g/l; albendazole oxide carbamate-benzimidazole active 36.0 g/l - parasiticides

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - paracetamol, quantity: 665 mg - tablet, modified release - excipient ingredients: hypromellose; magnesium stearate; microcrystalline cellulose; silicon dioxide; povidone; pregelatinised maize starch; purified water; croscarmellose sodium; titanium dioxide; macrogol 6000 - pharmacy action paracetamol osteo provides effective relief from persistent pain for up to 8 hours. effective for the relief of persistent pain associated with osteoarthritis and muscular aches and pains such as backache. provides effective temporary relief of pain and discomfort associated with: headache, tension headache, cold and flu, period pain, toothache and pain after dental procedures. reduces fever.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

victorian chemical company proprietary limited - alcohol alkoxylate - soluble concentrate - alcohol alkoxylate emulsifiers & surfactants active 1000.0 g/l - wetting agent

Australia - English - Department of Health (Therapeutic Goods Administration)

achieve correctness (australia) company proprietary limited - colloidal anhydrous silica, quantity: 10.9 mg (equivalent: silicon, qty 5.1 mg); inositol, quantity: 25 mg; panax ginseng, quantity: 12.5 mg (equivalent: panax ginseng, qty 50 mg); eclipta prostrata, quantity: 125 mg (equivalent: eclipta prostrata, qty 1.25 g); serenoa repens, quantity: 34.043 mg (equivalent: serenoa repens, qty 160 mg); ligustrum lucidum, quantity: 50 mg (equivalent: ligustrum lucidum, qty 500 mg); calcium pantothenate, quantity: 10.9 mg; biotin, quantity: 450 microgram; zinc amino acid chelate, quantity: 18.75 mg (equivalent: zinc, qty 3.75 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; chlorophyllin-copper complex; maltodextrin; calcium hydrogen phosphate dihydrate; titanium dioxide; calcium silicate; povidone; crospovidone; silicon dioxide; microcrystalline cellulose; dextrin; magnesium stearate; polysorbate 80; purified talc; macrogol 4000; polyvinyl alcohol - maintain/support collagen formation ; maintain/support hair growth ; maintain/support hair health ; decrease/reduce hair loss/thinning ; decrease/reduce nail brittleness/splitting/chipping ; maintain/support nail health/strength/thickness ; maintain/support skin health ; maintain/support skin integrity/structure

Australia - English - Department of Health (Therapeutic Goods Administration)

achieve correctness (australia) company proprietary limited - rosemary oil, quantity: 1.8 mg (equivalent: safrole, qty 0.09 microgram); ubidecarenone, quantity: 150 mg - capsule, soft - excipient ingredients: gelatin; lecithin; purified water; linseed oil; iron oxide red; glycerol; white beeswax; d-alpha-tocopherol; iron oxide yellow - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support energy production ; maintain/support general health and wellbeing ; maintain/support cardiovascular system health ; maintain/support healthy cardiovascular system function ; maintain/support heart health ; maintain/support immune system health ; maintain/support healthy immune system function